| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/20/2006 | WO2006040281A1 Thiazolyl-dihydro indazoles |
| 04/20/2006 | WO2006040050A1 Quinazolinylmethylene thiazolinones as cdk1 inhibitors |
| 04/20/2006 | WO2006025979A9 Modulators of nuclear receptors |
| 04/20/2006 | WO2006020156A3 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer’s disease |
| 04/20/2006 | WO2006019497A3 Sleep-inducing compounds and methods related thereto |
| 04/20/2006 | WO2006013393A3 Quinoline derivatives as neurokinin receptor antagonists |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084810 Antibacterial 1,3-oxazolidin-2-one derivatives |
| 04/20/2006 | US20060084804 e.g. 2-(1-hydroxymethyl-2-phenyl-ethylamino)-5-[1-quinazolin-6-yl-methylidene]-thiazol-4-one; cyclin-dependent kinases (CDKs)/serine-threonine protein kinases inhibitor; antiproliferative, anticarcinogenic, antitumor agent |
| 04/20/2006 | US20060084802 Modulate function of peroxisome proliferator-activated receptors (PPAR) gamma or PPAR delta; diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis; 2-Amino-5-bromo-isonicotinic acid methyl and ethyl esters; 2-amino-5-iodo-isonicotinic acid pentyl ester |
| 04/20/2006 | US20060084690 Isoxazole derivatives |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084687 N-(3-aminopropyl)-N-[(1R)-1-(1-benzyl-1H-benzimidazol-2-yl)-2-methylpropyl]-4-chlorobenzamide;kinesin spindle protein modulators; anticarcinogenic agents; in vivo stability, bio-availability; diagnosis/medical/;antitumor agents hyperplasia; restinosis; antiinflammatory agents; cardiac hypertrophy |
| 04/20/2006 | US20060084682 e.g. 5-{2-[6-(3,4-Dichloro-phenyl)-pyridin-2-yl]-1H-benzoimidazol-5-ylmethylene}-2-thioxo-thiozolidin; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084663 Alkanoic acids, nitriles and amides substituted with a group containing benzene ring linked through a thiazolyl- or oxazolyl- phenyl group; e.g., {4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-2-propyl-phenoxy}-acetic acid; treating diabetes and atherosclerosis |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084651 Chemical compounds |
| 04/20/2006 | US20060084645 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 04/20/2006 | US20060084644 Atherosclerosis, unwanted cellular growth or cellular proliferation, diabetes, inflammatory conditions and vascular occlusive pathologic conditions; novel compound 1-[4-(4-Hydroxy-6'-phenyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-ylamino)-phenyl]-ethanone; modulation of glycosidase enzymes |
| 04/20/2006 | US20060084576 Hetaryl substituted homotetramic and homotetronic acids and their use thereof as pesticides |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | CA2583311A1 Quinazolinylmethylenethiazolinones as cdk1 inhibitors |
| 04/20/2006 | CA2582202A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | CA2581516A1 Quinazoline derivatives |
| 04/20/2006 | CA2580480A1 Pi3 kinase gamma inhibitors for the treatment of anaemia |
| 04/20/2006 | CA2579288A1 Thiazolyldihydroindazoles |
| 04/19/2006 | EP1647553A1 2-acylaminothiazole derivative or salt thereof |
| 04/19/2006 | EP1646629A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/19/2006 | EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 04/19/2006 | EP1646613A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 04/19/2006 | EP1646611A1 Hydroxypyridine cgrp receptor antagonists |
| 04/19/2006 | EP1646392A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 04/19/2006 | EP1646384A1 Enema preparation |
| 04/19/2006 | EP1646382A2 Compounds, compositions and methods |
| 04/19/2006 | EP1423363B1 Oral antidiabetic agents |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1401439B1 Use of bicyclo compounds for treating alzheimer's disease |
| 04/19/2006 | EP1349833B1 Indole and dihydroindole derivatives |
| 04/19/2006 | EP1112284B1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761673A Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists |
| 04/19/2006 | CN1761655A Thiazole derivatives and their use as VAP-1 inhibitors |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252066C Pyridazine-3-one derivatives, their use, and intermediate preparing them |
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252054C Qinoline derivatives inhibiting effect of growth factors |
| 04/18/2006 | US7030150 Benzimidazole compounds and antiviral uses thereof |
| 04/18/2006 | US7030148 Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them |
| 04/18/2006 | US7030147 Synergistic mixture; antiproliferative agents; side effect reduction |
| 04/18/2006 | US7030143 Heterocyclic compounds |
| 04/18/2006 | US7030139 Compounds |
| 04/18/2006 | US7030138 Benzamidine derivatives |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030125 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 04/18/2006 | US7029835 Photothermographic element comprising improved base precursors and methods for their use |
| 04/14/2006 | WO2005032544A1 Treatment of mitochondrial diseases |
| 04/14/2006 | CA2580584A1 Use of alpha-tocotrienol for treatment of mitochondrial diseases |
| 04/13/2006 | WO2006039243A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006039215A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006038989A1 Substituted arylamides |
| 04/13/2006 | WO2006038871A1 New hydroxymethylbenzothiazoles amides |
| 04/13/2006 | WO2006038550A1 Medicinal composition for prevention or treatment of parasitic protozoan infection |
| 04/13/2006 | WO2006038513A1 Anti-trypanosomiasis agent |
| 04/13/2006 | WO2006038172A1 New piperidine antibiotics |
| 04/13/2006 | WO2006038100A1 Oxazolidinone derivatives as antimicrobials |
| 04/13/2006 | WO2006038006A2 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 04/13/2006 | WO2006028958A3 Pyridyl inhibitors of hedgehog signalling |
| 04/13/2006 | WO2005110416A3 4,5-disubstituted-2-aryl pyrimidines |
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | WO2005049559A3 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 04/13/2006 | US20060079693 Method and intermediate for preparing a prostaglandin F-type compound |
| 04/13/2006 | US20060079692 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 04/13/2006 | US20060079688 Process for producing acid adduct salt of polyacidic base compound |
| 04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
| 04/13/2006 | US20060079681 Process for exchanging anions in phenothiazinium derivatives |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079555 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/13/2006 | US20060079553 Quinoline derivatives as glucokinase ligands |
| 04/13/2006 | US20060079543 Several exemplified (pyrimidin-2-ylamino)benzenesulfonamide compounds such as N-phenyl-4-[(4-thien-2-ylpyrimidin-2-yl)amino]benzenesulfonamide; I kappa B kinase inhibitors (IKK inhibitors); anticancer agents, autoimmune diseases, osteoporosis |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079519 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease. |
| 04/13/2006 | US20060079518 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 04/13/2006 | US20060079504 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 04/13/2006 | US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors |
| 04/13/2006 | US20060079498 ((2S,4S)-4-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)pyrrolidin-2-yl)-(3,3-difluoropyrrolidin-1-yl)-methanone dihydrochloride; dipeptidyl peptidase-IV inhibitor; diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy |
| 04/13/2006 | US20060078351 Organophotoreceptors with a charge transport material having multiple vinyl-containing hydrazone groups |
| 04/13/2006 | DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives |
| 04/13/2006 | CA2583287A1 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 04/13/2006 | CA2582356A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2582347A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2581057A1 New piperidine antibiotics |
| 04/12/2006 | EP1645559A1 Process for the purification of meloxicam |
| 04/12/2006 | EP1644370A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644369A2 Arylamine-substituted quinazolinone compounds |
| 04/12/2006 | EP1644368A1 Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators |
| 04/12/2006 | EP1644357A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |